COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,624 Articles (22,913 medRxiv, 8,711 bioRxiv)

Most recent first Previous |  Page 1043: Articles 10421-10430  | Next

Protective effect of a first SARS-CoV-2 infection from reinfection: a matched retrospective cohort study using PCR testing data in England
Lacy, J., Mensah, A. A., Simmons, R., Andrews, N., Siddiqui, M. R., Bukasa, A., O'Boyle, S., Campbell, H., Brown, K. E.
10.1101/2022.01.10.22268896 — Posted: 2022-01-10
COVID-19-related school disruptions and well-being of children and adolescents in Geneva
Richard, V., Dumont, R., Lorthe, E., Baysson, H., Zaballa, M.-E., Barbe, R. P., Posfay-Barbe, K. M., Guessous, I., Stringhini, S.
10.1101/2022.01.07.21268224 — Posted: 2022-01-10
Epidemiology of SARS-CoV-2 infection in Italy using real-world data: methodology and cohort description of the second phase of web-based EPICOVID19 study.
Adorni, F., Jesuthasan, N., Perdixi, E., Sojic, A., Giacomelli, A., Noale, M., Trevisan, C., Franchini, M., Pieroni, S., Cori, L., Mastroianni, C. M., Bianchi, F., Antonelli Incalzi, R., Maggi, S., Galli, M., Prinelli, F.
10.1101/2022.01.10.22268897 — Posted: 2022-01-10
Omicron Impact in India: An Early Analysis of the Ongoing COVID-19 Third Wave
Ranjan, R.
10.1101/2022.01.09.22268969 — Posted: 2022-01-10
Durability and cross-reactivity of SARS-CoV-2 mRNA vaccine in adolescent children
Burns, M., Bartsch, Y., Boribong, B., Loiselle, M., Davis, J., Lima, R., Edlow, A., Fasano, A., Alter, G., Yonker, L.
10.1101/2022.01.05.22268617 — Posted: 2022-01-10
Prevalence of Salivary IgA Reacting with SARS-CoV-2 among Japanese People Unexposed to the Virus
Tsukinoki, K., Yamamoto, T., Saito, J., Sakaguchi, W., Iguchi, K., Inoue, Y., Ishii, S., Sato, C., Yokoyama, M., Shiraishi, Y., Kato, N., Shimada, H., Makabe, A., Saito, A., Tanji, K., Nagaoka, I., Saruta, J., Yamaguchi, T., Kimoto, S., Yamaguchi, H.
10.1101/2022.01.09.22268986 — Posted: 2022-01-10
Reconstructing transmission chains of SARS-CoV-2 amid multiple outbreaks in a geriatric acute-care hospital
Abbas, M., Cori, A., Cordey, S., Laubscher, F., Robalo Nunes, T., Myall, A., Salamun, J., Huber, P., Zekry, D., Prendki, V., Iten, A., Vieux, L., Sauvan, V., Graf, C. E., Harbarth, S.
10.1101/2022.01.07.22268729 — Posted: 2022-01-10
Adaptation and validation of a scale to evaluate the quality of virtual courses developed for medical students in Peru during the COVID-19 pandemic
Intimayta-Escalante, C., Plasencia-Duenas, R., Flores-Lovon, K. A., Nunez-Lupaca, J. N., Chavez-Hermosilla, M., Castillo-Blanco, R.
10.1101/2022.01.08.22268928 — Posted: 2022-01-10
Modelling COVID-19 Vaccine Breakthrough Infections in Highly Vaccinated Israel - the effects of waning immunity and third vaccination dose
Feng, A., Obolski, U., Stone, L., He, D.
10.1101/2022.01.08.22268950 — Posted: 2022-01-10
Estimation of the test to test distribution as a proxy for generation interval distribution for the Omicron variant in England
Abbott, S., Sherratt, K., Gerstung, M., Funk, S.
10.1101/2022.01.08.22268920 — Posted: 2022-01-10

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).